Encompass Health Reports Strong Q4 2025 Results with Significant Growth
Encompass Health's stock surged by 11.37% as it reached a 20-day high, reflecting strong investor interest following its recent earnings report.
The company reported a net operating revenue of $1.5446 billion for Q4 2025, a 9.9% increase from the previous year, and adjusted earnings per share rose to $1.46, exceeding analysts' expectations. This strong performance, coupled with an optimistic outlook for 2026, has significantly boosted investor confidence in Encompass Health's growth potential.
The impressive earnings growth and positive future guidance indicate that Encompass Health is well-positioned to capitalize on the increasing demand in the rehabilitation hospital market, which may lead to sustained stock performance in the upcoming quarters.
Trade with 70% Backtested Accuracy
Analyst Views on EHC
About EHC
About the author

- New Hospital Announcement: Encompass Health has announced plans to build a 36-bed freestanding rehabilitation hospital in Bridgeport, West Virginia, which will expand its former 19-bed unit to meet the growing rehabilitation care needs in the area.
- Facility and Service Enhancements: The new hospital will feature all private patient rooms, a state-of-the-art therapy gym, an activities of daily living suite, and an in-house dialysis suite, aiming to improve patient quality of life and functional recovery through comprehensive physical, occupational, and speech therapies.
- Expanded Patient Services: The hospital will focus on patients recovering from conditions such as stroke, neurological disorders, brain and spinal cord injuries, and complex orthopedic issues, providing 24-hour nursing care and specialized services from an interdisciplinary team to enhance recovery outcomes.
- Temporary Service Arrangements: During the construction of the new hospital, Encompass Health's Morgantown rehabilitation hospital has temporarily expanded its capacity to ensure continuity of care for patients, demonstrating the company's commitment to patient services.
- New Hospital Announcement: Encompass Health has announced plans to construct a freestanding 36-bed rehabilitation hospital in Bridgeport, West Virginia, aimed at expanding access to rehabilitation care for local patients in response to increasing demand in the area.
- Facility Enhancements: The new hospital will feature all private patient rooms, a state-of-the-art therapy gym, and an activities of daily living suite, which is expected to significantly enhance patient rehabilitation experiences and quality of life.
- Expanded Service Offerings: The hospital will provide 24-hour nursing care and physical, occupational, and speech therapies for patients recovering from strokes, neurological conditions, and spinal cord injuries, thereby strengthening Encompass Health's competitive position in the rehabilitation market.
- Temporary Care Arrangements: During the construction of the new hospital, Encompass Health's Morgantown rehabilitation hospital has temporarily expanded its capacity to ensure continuity of care for patients, demonstrating the company's commitment to patient service.

- Revenue Outlook Raised: BrightSpring has increased its 2026 revenue forecast to $14.725 billion to $15.225 billion, up from the previous range of $14.450 billion to $15.00 billion, indicating strong confidence in future growth, particularly in pharmacy and provider services.
- Profitability Improvement: The adjusted EBITDA range has been lifted to $795 million to $825 million, reflecting management's confidence in margin expansion, which is expected to offset revenue pressures from policy changes through efficiency gains and business integration.
- Strong Q1 Performance: BrightSpring reported adjusted earnings per share of 39 cents in the first quarter, exceeding the market expectation of 29 cents and more than doubling year-over-year, showcasing significant improvements in profitability and market competitiveness.
- Healthy Cash Flow Position: By the end of the first quarter, BrightSpring had $888.8 million in cash and cash equivalents, a substantial increase from $88.4 million in the prior quarter, indicating improved financial flexibility that supports future debt reduction and selective reinvestment.
- Financing Size: Encompass Health successfully priced a $500M offering of 5.875% senior notes, priced at 100% of principal value and maturing in 2034, demonstrating strong capital market access.
- Interest Payment Structure: Interest on the notes will be paid semiannually on June 1 and December 1, with the first payment scheduled for December 1, 2026, ensuring stable future cash flows and boosting investor confidence.
- Use of Proceeds: Proceeds will be used to redeem $400M of 4.500% senior notes and repay $100M under the senior secured revolving credit facility, optimizing the capital structure and reducing financial costs.
- Strategic Outlook: Encompass Health raised its 2026 revenue outlook to $6.375B-$6.470B while planning to open seven new hospitals, indicating a proactive strategic approach to business expansion and market share enhancement.
- Debt Redemption Announcement: Encompass Health has announced the redemption of $400 million of its 4.5% senior notes due 2028, with the redemption price set at 100% of par plus accrued interest, expected to be paid on June 15, 2026.
- Financial Impact: The company anticipates recording an approximate $3.2 million loss on early extinguishment of debt in Q2 2026, which will negatively affect its short-term financial performance.
- Bond Balance Status: As of May 14, 2026, the total outstanding amount of the 2028 senior notes was $800 million, and this redemption will reduce the company's debt burden, despite incurring a loss in the short term.
- Company Background: Encompass Health is the largest operator of inpatient rehabilitation hospitals in the U.S., with 175 facilities providing high-quality rehabilitative care, and despite facing financial challenges, it is recognized as America's Most Awarded Leader in Inpatient Rehabilitation.
- Bond Offering Initiative: Encompass Health (EHC) has commenced a private offering of $500 million in senior notes due 2034, reflecting the company's proactive financing strategy in the capital markets.
- Guarantee Structure: The notes will be guaranteed on a senior unsecured basis by the company's subsidiaries, which also guarantee its credit agreement and other capital market debts, enhancing the credit rating of the bonds.
- Use of Proceeds: EHC plans to use the proceeds along with available cash to redeem $400 million of its outstanding 4.500% senior notes due 2028 at par, aiming to reduce interest burdens and optimize its capital structure.
- Credit Facility Repayment: Part of the proceeds will also be allocated to repay $100 million outstanding under its senior secured revolving credit facility, further improving the company's liquidity and financial flexibility.









